Methotrexate is effective in reactivated colitis and reduces inflammatory alterations in mesenteric adipose tissue during intestinal inflammation

Pharmacological Research

Volumn 60, Issue 4, 2009, Pages 341-346

  Thomaz, Marcia Aparecida ^a   Acedo, Simone Coghetto ^a   de Oliveira, Caroline Candida ^a   Pereira, José Aires ^a   Priolli, Denise Gonçalves ^a   Saad, Mario José ^b   Pedrazzoli Jr , José ^a   Gambero, Alessandra ^a  

^a Universidade Sao Francisco Centro de Ciencias Biologicas e da Saude   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Adiponectin; F4 80; IL 10; iNOS; Leptin; TLR 4; TNBS; TNF

Indexed keywords

ADIPONECTIN; ALCOHOL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LEPTIN; METHOTREXATE; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME ACTIVITY; HISTOPATHOLOGY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TH1 CELL; TH2 CELL; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; CELL MOVEMENT; COLITIS; CYTOKINES; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; MACROPHAGES; MALE; METHOTREXATE; RATS; RATS, WISTAR;

EID: 69249202463     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.05.003     Document Type: Article

References (36)

1. Karmiris K., Koutroubakis I.E., and Kouroumalis E.A. Leptin, adiponectin, resistin, and ghrelin-implications for inflammatory bowel disease. Mol Nutr Food Res 52 (2008) 855-866
2. Pond C.M. Long-term changes in adipose tissue in human disease. Proc Nutr Soc 60 (2001) 365-374
3. Sheehan A.L., Warren B.F., Gear M.W., and Shepherd N.A. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 79 (1992) 955-958
4. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 56 (2007) 577-583
5. Paul G., Schäffler A., Neumeier M., Fürst A., Bataillle F., Buechler C., et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 12 (2006) 471-477
6. Schäffler A., Fürst A., Büchler C., Paul G., Rogler G., Schölmerich J., et al. Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment. J Gastroenterol Hepatol 21 (2006) 1412-1418
7. Desreumaux P., Ernst O., Geboes K., Gambiez L., Berrebi D., Müller-Alouf H., et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 117 (1999) 73-81
8. Travis S.P., Stange E.F., Lémann M., Oresland T., Chowers Y., Forbes A., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 55 (2006) i16-35
9. Faubion Jr. W.A., Loftus Jr. E.V., Harmsen W.S., Zinsmeister A.R., and Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121 (2001) 255-260
10. Tian H., and Cronstein B.N. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull Hosp Jt Dis (NYU) 65 (2007) 168-173
11. Majumdar S., and Aggarwal B.B. Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. J Immunol 167 (2001) 2911-2920
12. Gambero A., Maróstica M., Abdalla Saad M.J., and Pedrazzoli Jr. J. Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm Bowel Dis 13 (2007) 1357-1364
13. de Oliveira C.C., Acedo S.C., Saad M.J., Pedrazzoli Jr. J., and Gambero A. Depot-specific alterations to insulin signaling in mesenteric adipose tissue during intestinal inflammatory response. Int Immunopharmacol 9 (2009) 396-402
14. Bell C.J., Gall D.G., and Wallace J.L. Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 268 (1995) G622-G630
15. Appleyard C.B., and Wallace J.L. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269 (1995) G119-G125
16. Lee J.H., Lee B., Lee H.S., Bae E.A., Lee H., Ahn Y.T., et al. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis 24 (2009) 231-237
17. Gálvez J., Garrido M., Rodríguez-Cabezas M.E., Ramis I., de Medina F.S., Merlos M., et al. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production. Inflamm Bowel Dis 9 (2003) 363-371
18. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., and Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182 (1995) 1281-1290
19. Graffner-Nordberg M., Fyfe M., Brattsand R., Mellgård B., and Hallberg A. Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group, Evaluation in a mouse colitis model. J Med Chem 46 (2003) 3455-3462
20. Melgar S., Karlsson L., Rehnström E., Karlsson A., Utkovic H., Jansson L., et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol 8 (2008) 836-844
21. Du F., Lü L.J., Fu Q., Dai M., Teng J.L., Fan W., et al. T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis. Arthritis Res Ther 10 (2008) R136
22. Tekeoglu I., Dogan A., Ediz L., Budancamanak M., and Demirel A. Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytother Res 21 (2007) 895-897
23. Couper K.N., Blount D.G., and Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 180 (2008) 5771-5777
24. Li M.C., and He S.H. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 10 (2004) 620-625
25. Zhang M., Deng C.S., Zheng J.J., and Xia J. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis. Acta Pharmacol Sin 27 (2006) 1071-1077
26. Herman S., Zurgil N., Langevitz P., Ehrenfeld M., and Deutsch M. Methotrexate selectively modulates Th1/Th2 balance in active rheumatoid arthritis patients. Clin Exp Rheumatol 26 (2008) 317-323
27. Frolova L., Drastich P., Rossmann P., Klimesova K., and Tlaskalova-Hogenova H. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem 56 (2008) 267-274
28. Arranz A., Abad C., Juarranz Y., Torroba M., Rosignoli F., Leceta J., et al. Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis. Ann N Y Acad Sci 1070 (2006) 129-134
29. Lubbad A., Oriowo M.A., and Khan I. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Mol Cell Biochem 322 (2009) 127-135
30. Yue G., Lai P.S., Yin K., Sun F.F., Nagele R.G., Liu X., et al. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther 297 (2001) 915-925
31. Camacho-Barquero L., Villegas I., Sánchez-Calvo J.M., Talero E., Sánchez-Fidalgo S., Motilva V., et al. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7 (2007) 333-342
32. Yu R., Kim C.S., Kwon B.S., and Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity 14 (2006) 1353-1362
33. Robker R.L., Collins R.G., Beaudet A.L., Mersmann H.J., and Smith C.W. Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res 12 (2004) 936-940
34. Brake D.K., Smith E.O., Mersmann H., Smith C.W., and Robker R.L. ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 291 (2006) C1232-C1239
35. Visvanathan S., Marini J.C., Smolen J.S., Clair E.W., Pritchard C., Shergy W., et al. Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis. J Rheumatol 34 (2007) 1465-1474
36. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 (2003) 1779-1785